We are live on ! Find out more
Primecap Management

Primecap Management Portfolio holdings

AUM $169B Turnover 4.85%
1-Year Est. Return 114.72%
This Fund
S&P 500
This Quarter Est. Return
+10.92%
1 Year Est. Return
+114.72%
3 Year Est. Return
+234.44%
5 Year Est. Return
+291.25%
10 Year Est. Return
+1,263.36%
AUM
$126B
AUM Growth
+$7.85B
Cap. Flow
-$3.09B
Cap. Flow %
-2.45%
Top 10 Hldgs %
35.91%
Holding
339
New
8
Increased
67
Reduced
188
Closed
5
Avg Time Held
6.1 years
Top 10 Avg Time Held
4.9 years
Top 20 Avg Time Held
5.6 years

Top Buys

Rank Stock Value
1
ALB icon
Albemarle
ALB
+$171M
2
BMY icon
Bristol-Myers Squibb
BMY
+$157M
3
NFE icon
New Fortress Energy
NFE
+$100M
4
BABA icon
Alibaba
BABA
+$70.3M
5
BA icon
Boeing
BA
+$64M

Sector Composition

Rank Sector Weight
1 Technology 31.7%
2 Healthcare 30.82%
3 Industrials 11.15%
4 Consumer Discretionary 9.2%
5 Financials 7.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
RJF icon
26
Raymond James Financial
RJF
$30.3B
$1.37B 1.09%
12,317,607
-251,520
-2% -$25.9M
2018 Q4
20 quarters
NVS icon
27
Novartis
NVS
$286B
$1.3B 1.03%
12,905,697
-1,689,455
-12% -$163M
2013 Q2
42 quarters
NTAP icon
28
NetApp
NTAP
$42.2B
$1.3B 1.03%
14,709,824
-530,990
-3% -$42.7M
2013 Q2
42 quarters
ACM icon
29
Aecom
ACM
$7.6B
$1.29B 1.03%
14,009,719
-575,660
-4% -$48.9M
2013 Q2
42 quarters
NVDA icon
30
NVIDIA
NVDA
$5.25T
$1.28B 1.01%
25,767,300
-114,650
-0.4% -$5.31M
2013 Q2
42 quarters
TJX icon
31
TJX Companies
TJX
$159B
$1.27B 1%
13,491,848
-75,800
-0.6% -$6.8M
2013 Q2
42 quarters
BMY icon
32
Bristol-Myers Squibb
BMY
$124B
$1.21B 0.96%
23,534,378
+2,998,228
+15% +$157M
2017 Q1
27 quarters
HES icon
33
DELISTED
Hess
HES
$1.15B 0.91%
7,970,450
-136,385
-2% -$20M
2018 Q3
21 quarters
BIDU icon
34
Baidu
BIDU
$28.1B
$1.11B 0.88%
9,283,034
+12,480
+0.1% +$1.44M
2019 Q4
16 quarters
INTU icon
35
Intuit
INTU
$88.2B
$1.09B 0.86%
1,736,031
-21,455
-1% -$11.8M
2013 Q2
42 quarters
PXD icon
36
DELISTED
Pioneer Natural Resource Co.
PXD
$1.07B 0.85%
4,760,256
-86,100
-2% -$20.2M
2017 Q3
25 quarters
V icon
37
Visa
V
$750B
$1.05B 0.83%
4,046,151
+5,820
+0.1% +$1.43M
2013 Q2
42 quarters
UAL icon
38
United Airlines
UAL
$32.9B
$964M 0.76%
23,353,324
-116,110
-0.5% -$4.57M
2013 Q2
42 quarters
ONC icon
39
BeOne Medicines Ltd
ONC
$42.3B
$900M 0.71%
4,988,639
-20,100
-0.4% -$3.64M
2017 Q2
26 quarters
DAL icon
40
Delta Air Lines
DAL
$51.4B
$893M 0.71%
22,199,858
-49,910
-0.2% -$1.81M
2013 Q2
42 quarters
J icon
41
Jacobs Solutions
J
$16.6B
$791M 0.63%
7,371,213
-154,174
-2% -$16.8M
2013 Q2
42 quarters
MAT icon
42
Mattel
MAT
$4.95B
$777M 0.62%
41,178,489
-438,300
-1% -$8.53M
2017 Q2
26 quarters
RCL icon
43
Royal Caribbean
RCL
$74.9B
$777M 0.62%
6,001,561
-190,300
-3% -$19.4M
2013 Q2
42 quarters
JPM icon
44
JPMorgan Chase
JPM
$891B
$770M 0.61%
4,524,046
-824,900
-15% -$125M
2015 Q1
35 quarters
ELAN icon
45
Elanco Animal Health
ELAN
$11.8B
$754M 0.6%
50,600,324
+1,431,665
+3% +$16.2M
2018 Q3
21 quarters
QCOM icon
46
Qualcomm
QCOM
$191B
$754M 0.6%
5,211,042
-681,455
-12% -$84.4M
2013 Q2
42 quarters
ADI icon
47
Analog Devices
ADI
$196B
$726M 0.57%
3,656,705
-46,080
-1% -$8.23M
2013 Q2
42 quarters
AMZN icon
48
Amazon
AMZN
$2.75T
$657M 0.52%
4,325,350
+17,000
+0.4% +$2.38M
2013 Q2
42 quarters
HPQ icon
49
HP
HPQ
$27.8B
$626M 0.5%
20,801,915
+35,240
+0.2% +$987K
2013 Q2
42 quarters
ZBH icon
50
Zimmer Biomet
ZBH
$18B
$619M 0.49%
5,086,578
+484,151
+11% +$54M
2013 Q2
42 quarters

Similar funds

Primecap Management's Q4 2023 Portfolio in Review

As of Q4 2023, Primecap Management held 339 positions worth $126B, up 6.6% from $118B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Trading was light in Q4 2023: portfolio turnover was 3.8%. Primecap Management opened 8 new positions and exited 5, leaving the 339-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Healthcare and Industrials.

  • Primecap Management's largest Q4 2023 buy was Boeing: 299,300 shares worth $78M.
  • Primecap Management added most to Albemarle in Q4 2023, an estimated $171M increase.
  • Primecap Management's biggest Q4 2023 reduction was Eli Lilly, cutting an estimated $504M.
  • Primecap Management fully exited Seagen Inc. Common Stock in Q4 2023, selling an estimated $1.33B.
  • Primecap Management's ten largest holdings make up 36% of its $126B portfolio in Q4 2023.
  • Primecap Management opened 8 new positions and closed 5 in Q4 2023.
  • Primecap Management's portfolio value rose 6.6% quarter-over-quarter to $126B.

Based on Primecap Management's 13F filing for Q4 2023, filed 9 Feb 2024.